UY34081A - Composición farmacéutica que comprende drotaverina - Google Patents

Composición farmacéutica que comprende drotaverina

Info

Publication number
UY34081A
UY34081A UY0001034081A UY34081A UY34081A UY 34081 A UY34081 A UY 34081A UY 0001034081 A UY0001034081 A UY 0001034081A UY 34081 A UY34081 A UY 34081A UY 34081 A UY34081 A UY 34081A
Authority
UY
Uruguay
Prior art keywords
drotaverina
pharmaceutical composition
composition including
pag
escanear
Prior art date
Application number
UY0001034081A
Other languages
English (en)
Inventor
Badabhagni Sudhakara Rao
Nilesh Jaiswal
Praveen Khullar
K U M Prasad
Original Assignee
Chinoin Private Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Private Co Ltd filed Critical Chinoin Private Co Ltd
Publication of UY34081A publication Critical patent/UY34081A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

La presente invención se refiere a una composición farmacéutica de hidrocloruro de drotaverina en un sistema de disolvente adecuada como una composición líquida de relleno. En otro aspecto, la invención también se refiere a un proceso para la preparación de dicha composición farmacéutica y al uso de dicha composición para la preparación de un producto farmacéutico para tratar espasmos y dolores agudos.
UY0001034081A 2011-05-20 2012-05-18 Composición farmacéutica que comprende drotaverina UY34081A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1728CH2011 2011-05-20
US201161499850P 2011-06-22 2011-06-22
EP11305922 2011-07-13

Publications (1)

Publication Number Publication Date
UY34081A true UY34081A (es) 2013-01-03

Family

ID=47216628

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034081A UY34081A (es) 2011-05-20 2012-05-18 Composición farmacéutica que comprende drotaverina

Country Status (10)

Country Link
US (1) US20140080864A1 (es)
EP (1) EP2709599B1 (es)
AR (1) AR086448A1 (es)
BR (1) BR112013029621A2 (es)
EA (1) EA022944B1 (es)
HU (1) HUE038538T2 (es)
MX (1) MX354485B (es)
PL (1) PL2709599T3 (es)
UY (1) UY34081A (es)
WO (1) WO2012159964A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279346A (zh) 2020-03-09 2022-11-01 苏什玛·保罗·伯利亚 包含屈他维林或其盐的控制释放制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197207B (en) * 1985-12-04 1989-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient
HUT60926A (en) * 1991-04-12 1992-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition suitable for reducing or preventing increased thrombocyte-aggregation capability
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents

Also Published As

Publication number Publication date
MX2013013574A (es) 2014-09-22
EP2709599A1 (en) 2014-03-26
US20140080864A1 (en) 2014-03-20
EA201391743A1 (ru) 2014-03-31
AR086448A1 (es) 2013-12-11
WO2012159964A1 (en) 2012-11-29
BR112013029621A2 (pt) 2016-12-13
HUE038538T2 (hu) 2018-10-29
MX354485B (es) 2018-03-07
EA022944B1 (ru) 2016-03-31
EP2709599B1 (en) 2017-12-20
PL2709599T3 (pl) 2018-07-31

Similar Documents

Publication Publication Date Title
UY34550A (es) Bencilpirazoles sustituidos
UY34145A (es) Compuestos inhibidores de metaloenzimas
UY34146A (es) Compuestos inhibidores de metaloenzimas
UY34472A (es) Derivados modificados de 4-fenil-piridina
UY34523A (es) Derivados de betulina
UY34591A (es) Compuestos de imidazopirrolidinona
UY34763A (es) Inhibidores de la agregación plaquetaria
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34045A (es) Derivados de imidazopiridina como inhibidores de pi3k
UY34374A (es) Benzilindazoles sustituidos
UY34365A (es) Compuestos heterociclicos
UY34817A (es) Tienopirimidinas
UY4175Q (es) Reloj pulsera
UY33930A (es) Inhibidores novedosos de quinasas
UY34034A (es) Triazolopiridinas
UY34654A (es) Inhibidores de la beta-secretasa
BR112014001219A2 (pt) perfume
UY33906A (es) Composiciones herbicidas que comprenden topramezona
UY34006A (es) Imidazopiridazinas
BR112013025866A2 (pt) formulações com viscosidade reduzida
UY34138A (es) Antagonistas de trpv4
UY4281Q (es) Juguera
UY34198A (es) NUEVOS ANTAGONISTAS DE CRTh2
UY34197A (es) NUEVOS ANTAGONISTAS DE CRTh2
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201019